Jian Yuan Goh

Title: Innovations in Cancer Risk Assessment by Jian Yuan Goh

Introduction

Jian Yuan Goh is a notable inventor based in Singapore, recognized for his contributions to cancer research. His innovative methods focus on identifying the risk of cancer and providing therapeutic options for affected individuals. With a keen interest in genomic research, Goh has made significant strides in understanding cancer risk factors.

Latest Patents

Goh holds a patent for a method of identifying the risk of cancer in human subjects. This method involves determining whether a copy number amplification of at least one continuous genomic region specific to human chromosome 1q21 is present in a biological sample. The presence of this amplification indicates an elevated risk of cancer. Additionally, Goh's patent outlines a method for treating cancer in subjects with this specific genomic alteration by administering therapeutic agents capable of suppressing IRAK1, IRAK4, or a member of the S100 family, such as Pacritinib.

Career Highlights

Throughout his career, Jian Yuan Goh has worked with esteemed organizations, including the Agency for Science, Technology and Research and Tan Tock Seng Hospital Pte Ltd. His work in these institutions has allowed him to collaborate with leading experts in the field of cancer research and contribute to advancements in therapeutic strategies.

Collaborations

Goh has collaborated with notable colleagues, including Qiang Yu and Min Feng. Their combined expertise has fostered a productive research environment, leading to innovative solutions in cancer risk assessment and treatment.

Conclusion

Jian Yuan Goh's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer research. His patented methods for identifying cancer risk and therapeutic options represent a significant advancement in the field. Goh's contributions continue to impact the lives of many individuals facing cancer risks.